PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence

This study is evaluating the use of a specific type of PET scan — using a radiotracer called flotufolastat F-18 (which targets PSMA, a protein found on prostate cancer cells) — to detect recurrent prostate cancer at very low PSA levels after prostate removal surgery. The goal is to find cancer earlier, before it fully returns. **You may be eligible if...** - You previously had prostate cancer treated with radical prostatectomy (surgical prostate removal) with the intent to cure - Your PSA level is now elevated — at least 0.1 ng/mL but less than 0.5 ng/mL — suggesting possible cancer recurrence **You may NOT be eligible if...** - You are planning to receive a contrast dye or another PET radiotracer within 24 hours before the scan - You are currently receiving androgen deprivation therapy (hormone therapy) Talk to your doctor to see if this trial is right for you.